Sarcome-13/OS2016 Trial Protocol: a Multicentre, Randomised, Open-Label, Phase II Trial of Mifamurtide Combined with Postoperative Chemotherapy for Patients with Newly Diagnosed High-Risk Osteosarcoma.
BMJ Open（2019）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要